755025-16-2

Usage

Uses

Used in Pharmaceutical Industry:
(3S)-1-[(2,4-dimethoxyphenyl)methyl]-5-oxopyrrolidine-3-carboxylic acid is used as a pharmaceutical intermediate for the development of drugs targeting various diseases. Its unique structure and the presence of the 2,4-dimethoxyphenyl group may provide it with specific pharmacological properties, making it a valuable compound for drug discovery and medicinal chemistry.
Used in Biochemical Research:
In the field of biochemical research, (3S)-1-[(2,4-dimethoxyphenyl)methyl]-5-oxopyrrolidine-3-carboxylic acid serves as a valuable tool for studying the role of proline and its derivatives in protein synthesis and other biological processes. Its unique structure allows researchers to investigate the effects of specific modifications on protein function and stability.
Used in Peptide and Protein Synthesis:
(3S)-1-[(2,4-dimethoxyphenyl)methyl]-5-oxopyrrolidine-3-carboxylic acid is utilized as a building block in the synthesis of peptides and proteins with specific functions or properties. Its incorporation into peptide sequences can potentially alter the conformation, stability, or activity of the resulting protein, providing a means to create novel bioactive molecules with tailored characteristics.

Upstream product

• 1426408-67-4 (S)-4-benzyl-3-[(S)-1-(2,4-dimethoxybenzyl)-5-oxopyrrolidine-3-carbonyl]-2-oxazolidinone 
• 97-65-4 2-methylenesuccinic acid 
• 20781-20-8 2,4-Dimethoxybenzylamine 
• 304858-45-5 1-(2,4-dimethoxybenzyl)-5-oxopyrrolidine-3-carboxylic acid 

Downstream Products

• 1426404-42-3 (S)-5-oxopyrrolidine-3-carboxylic acid {5-[3-fluoro-5-((R)-2,2,2-trifluoro-1-methylethoxymethyl)phenyl]-1-phenyl-1H-pyrazol-3-yl}amide 
• 1426404-44-5 (S)-5-oxopyrrolidine-3-carboxylic acid {1-(2-fluorophenyl)-5-[3-fluoro-5-((R)-2,2,2-trifluoro-1-methylethoxymethyl)phenyl]-1H-pyrazol-3-yl}amide 
• 1426404-45-6 (S)-5-oxopyrrolidine-3-carboxylic acid {1-(4-fluorophenyl)-5-[3-((R)-2,2,2-trifluoro-1-methylethoxymethyl)phenyl]-1H-pyrazol-3-yl}amide 
• 1426404-46-7 (S)-5-oxopyrrolidine-3-carboxylic acid {1-(4-fluorophenyl)-5-[3-fluoro-5-((R)-2,2,2-trifluoro-1-methylethoxymethyl)phenyl]-1H-pyrazol-3-yl}amide 
• 1426404-48-9 (S)-5-oxopyrrolidine-3-carboxylic acid {5-[3-chloro-5-((R)-2,2,2-trifluoro-1-methylethoxymethyl)phenyl]-1-phenyl-1H-pyrazol-3-yl}amide 
• 1426404-49-0 (S)-5-oxopyrrolidine-3-carboxylic acid {5-[3-chloro-5-((R)-2,2,2-trifluoro-1-methylethoxymethyl)phenyl]-1-(4-fluorophenyl)-1H-pyrazol-3-yl}amide 
• 1426404-50-3 (S)-5-oxopyrrolidine-3-carboxylic acid [5-[3-chloro-5-(2,2,2-trifluoro-1,1-dimethylethoxymethyl)phenyl]-1-phenyl-1H-pyrazol-3-yl]amide 
• 1426404-51-4 (S)-5-oxopyrrolidine-3-carboxylic acid {1-(4-chlorophenyl)-5-[3-((R)-2,2,2-trifluoro-1-methylethoxymethyl)phenyl]-1H-pyrazol-3-yl}amide 
• 1426404-53-6 (S)-5-oxopyrrolidine-3-carboxylic acid {1-phenyl-5-[3-(2,2,2-trifluoro-1-trifluoromethylethoxymethyl)phenyl]-1H-pyrazol-3-yl}amide 
• 1426404-54-7 (S)-5-oxopyrrolidine-3-carboxylic acid {1-(4-fluorophenyl)-5-[3-(2,2,2-trifluoroethoxymethyl)phenyl]-1H-pyrazol-3-yl}amide 
• 1426404-55-8 (S)-5-oxopyrrolidine-3-carboxylic acid {1-(4-fluorophenyl)-5-[3-fluoro-5-(2,2,2-trifluoroethoxymethyl)phenyl]-1H-pyrazol-3-yl}amide 
• 1426404-43-4 (S)-5-oxopyrrolidine-3-carboxylic acid {1-(4-chlorophenyl)-5-[3-fluoro-5-((R)-2,2,2-trifluoro-1-methylethoxymethyl)phenyl]-1H-pyrazol-3-yl}amide 

Relevant academic research and scientific papers

PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

The present invention provides a pyrazole compound of the following general Formula [1b] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use wherein each symbol is the same as defined in the description